| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0024400 | Exon-Exon | chr3:172050879-172055191 | chr3:172333089-172337401 | 72 nt | 0.4167 |
| hsa_FNDC3B_0024500 | Exon-Exon | chr3:172050879-172065151 | chr3:172333089-172347361 | 150 nt | 0.4467 |
| hsa_FNDC3B_0024800 | Exon-Exon | chr3:172053314-172053449 | chr3:172335524-172335659 | 136 nt | 0.2941 |
| hsa_FNDC3B_0024900 | Exon-Exon | chr3:172055120-172064230 | chr3:172337330-172346440 | 584 nt | 0.5223 |
| hsa_chr3_0368400 | Intergenic-Intergenic | chr3:172058325-172058545 | chr3:172340535-172340755 | 221 nt | 0.5113 |
| hsa_FNDC3B_0025100 | Exon-Exon | chr3:172060801-172065151 | chr3:172343011-172347361 | 543 nt | 0.5083 |
| hsa_FNDC3B_0025200 | Exon-Exon | chr3:172060801-172070873 | chr3:172343011-172353083 | 824 nt | 0.5194 |
| hsa_chr3_0368500 | Intergenic-Intergenic | chr3:172061995-172065122 | chr3:172344205-172347332 | 54 nt | 0.5926 |
| hsa_FNDC3B_0025400 | Intron-Exon | chr3:172063360-172064218 | chr3:172345570-172346428 | 859 nt | 0.3737 |
| hsa_chr3_0368600 | Intergenic-Intergenic | chr3:172063462-172063944 | chr3:172345672-172346154 | 483 nt | 0.3602 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].